Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001493152-25-018449·Karyopharm Therapeutics Inc.
Schedule 13G ownership disclosure
Karyopharm Therapeutics Inc
Common Stock, no par value · CUSIP: 48576U205
Event date: 2025-10-10
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Opaleye Management Inc.
Shares: 1,569,002.00 · Class: 9.48%
- Opaleye, L.P.
Shares: 1,569,002.00 · Class: 9.48%
- James Silverman
Shares: 1,569,002.00 · Class: 9.48%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-018449
- Form type
- SCHEDULE 13G
- Filer
- Karyopharm Therapeutics Inc.
- CIK
- CIK 1503802
- Filed
- Oct 17, 2025
- Reporting period
- Oct 10, 2025
- Description
- Schedule 13G beneficial ownership